GILEAD SCIENCES INC (1GILD.MI) Stock Price, Quote, News and Overview
BIT:1GILD - Euronext Milan - US3755581036 - Common Stock - Currency: EUR
1GILD.MI Quote, Performance and Key Statistics
BIT:1GILD (2/10/2025, 7:00:00 PM)
92.44
-3.63 (-3.78%)
The current stock price of 1GILD.MI is 92.44 EUR. In the past month the price increased by 54.53%.
1GILD.MI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 19.53 | 334.80B | ||
| AMG.DE | AMGEN INC | 14.84 | 151.41B | ||
| GIS.DE | GILEAD SCIENCES INC | 23.43 | 129.01B | ||
| 1VRTX.MI | VERTEX PHARMACEUTICALS INC | 1627.14 | 117.04B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1592.5 | 114.55B | ||
| ARGX.BR | ARGENX SE | N/A | 37.42B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 27.55B | ||
| IDP.DE | BIOGEN INC | 8.26 | 19.00B | ||
| 0QF.DE | MODERNA INC | N/A | 12.71B | ||
| 1MRNA.MI | MODERNA INC | N/A | 12.02B | ||
| GLPG.AS | GALAPAGOS NV | 8.12 | 1.68B | ||
| BIO.DE | BIOTEST AG | 23.86 | 1.61B |
Related stock screener links
About 1GILD.MI
Company Profile
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 18,000 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. The company is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The firm operates in more than 35 countries.
Company Info
GILEAD SCIENCES INC
333 Lakeside Dr
Foster City CALIFORNIA US
Employees: 18000
Company Website: https://www.gilead.com/
Investor Relations: https://investors.gilead.com/
Phone: 16505743000
GILEAD SCIENCES INC / 1GILD.MI FAQ
What is the stock price of GILEAD SCIENCES INC today?
The current stock price of 1GILD.MI is 92.44 EUR. The price decreased by -3.78% in the last trading session.
What is the ticker symbol for GILEAD SCIENCES INC stock?
The exchange symbol of GILEAD SCIENCES INC is 1GILD and it is listed on the Euronext Milan exchange.
On which exchange is 1GILD.MI stock listed?
1GILD.MI stock is listed on the Euronext Milan exchange.
What is the price forecast or stock price prediction for GILEAD SCIENCES INC stock?
38 analysts have analysed 1GILD.MI and the average price target is 96.73 EUR. This implies a price increase of 4.64% is expected in the next year compared to the current price of 92.44. Check the GILEAD SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GILEAD SCIENCES INC worth?
GILEAD SCIENCES INC (1GILD.MI) has a market capitalization of 115.18B EUR. This makes 1GILD.MI a Large Cap stock.
How many employees does GILEAD SCIENCES INC have?
GILEAD SCIENCES INC (1GILD.MI) currently has 18000 employees.
What are the support and resistance levels for GILEAD SCIENCES INC (1GILD.MI) stock?
GILEAD SCIENCES INC (1GILD.MI) has a support level at 87. Check the full technical report for a detailed analysis of 1GILD.MI support and resistance levels.
Is GILEAD SCIENCES INC (1GILD.MI) expected to grow?
The Revenue of GILEAD SCIENCES INC (1GILD.MI) is expected to grow by 0.39% in the next year. Check the estimates tab for more information on the 1GILD.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GILEAD SCIENCES INC (1GILD.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 1GILD.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 1GILD.MI, evaluating the profitability, health, valuation and growth aspects
- GILEAD SCIENCES INC (1GILD.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GILEAD SCIENCES INC (1GILD.MI) Sales and EPS estimates to see what analysts future expectations are.
- GILEAD SCIENCES INC (1GILD.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GILEAD SCIENCES INC (1GILD.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- GILEAD SCIENCES INC (1GILD.MI) Stock Chart to make your own analysis
- GILEAD SCIENCES INC (1GILD.MI) Latest news and press-releases to stay up to date.
Does GILEAD SCIENCES INC (1GILD.MI) stock pay dividends?
GILEAD SCIENCES INC (1GILD.MI) has a dividend yield of 2.98%. The yearly dividend amount is currently 3.06. Check the full fundamental report for a detailed analysis of 1GILD.MI dividend history, reliability and sustainability.
When does GILEAD SCIENCES INC (1GILD.MI) report earnings?
GILEAD SCIENCES INC (1GILD.MI) will report earnings on 2025-04-23, after the market close.
What is the Price/Earnings (PE) ratio of GILEAD SCIENCES INC (1GILD.MI)?
The PE ratio for GILEAD SCIENCES INC (1GILD.MI) is 20.91. This is based on the reported non-GAAP earnings per share of 4.42 and the current share price of 92.44 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1GILD.MI.
1GILD.MI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to 1GILD.MI.
1GILD.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1GILD.MI. While 1GILD.MI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
1GILD.MI Financial Highlights
Over the last trailing twelve months 1GILD.MI reported a non-GAAP Earnings per Share(EPS) of 4.42. The EPS decreased by -34.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.45% | ||
| ROA | 0.23% | ||
| ROE | 0.69% | ||
| Debt/Equity | 0 |
1GILD.MI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to 1GILD.MI. The Buy consensus is the average rating of analysts ratings from 38 analysts.
For the next year, analysts expect an EPS growth of 71.54% and a revenue growth 0.39% for 1GILD.MI